These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36752169)

  • 1. Microfluidic synthesis of multilayered lipid-polymer hybrid nanoparticles for the formulation of low solubility drugs.
    Kambar N; Leal C
    Soft Matter; 2023 Feb; 19(8):1596-1605. PubMed ID: 36752169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid vesicles from lipids and block copolymers: Phase behavior from the micro- to the nano-scale.
    Magnani C; Montis C; Mangiapia G; Mingotaud AF; Mingotaud C; Roux C; Joseph P; Berti D; Lonetti B
    Colloids Surf B Biointerfaces; 2018 Aug; 168():18-28. PubMed ID: 29395385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics for the Production of Nanomedicines: Considerations for Polymer and Lipid-based Systems.
    Streck S; Hong L; Boyd BJ; McDowell A
    Pharm Nanotechnol; 2019; 7(6):423-443. PubMed ID: 31629401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
    Teixeira MC; Carbone C; Souto EB
    Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling the localization of polymer-functionalized nanoparticles in mixed lipid/polymer membranes.
    Olubummo A; Schulz M; Lechner BD; Scholtysek P; Bacia K; Blume A; Kressler J; Binder WH
    ACS Nano; 2012 Oct; 6(10):8713-27. PubMed ID: 22950802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery.
    Wei W; Sun J; Guo XY; Chen X; Wang R; Qiu C; Zhang HT; Pang WH; Wang JC; Zhang Q
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14839-14854. PubMed ID: 32182035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane mixing and dynamics in hybrid POPC/poly(1,2-butadiene-
    Seneviratne R; Catania R; Rappolt M; Jeuken LJC; Beales PA
    Soft Matter; 2022 Feb; 18(6):1294-1301. PubMed ID: 35048939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic Nanoparticles for Drug Delivery.
    Liu Y; Yang G; Hui Y; Ranaweera S; Zhao CX
    Small; 2022 Sep; 18(36):e2106580. PubMed ID: 35396770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.
    Mukherjee A; Waters AK; Kalyan P; Achrol AS; Kesari S; Yenugonda VM
    Int J Nanomedicine; 2019; 14():1937-1952. PubMed ID: 30936695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery.
    Li Y; Huang X; Lee RJ; Qi Y; Wang K; Hao F; Zhang Y; Lu J; Meng Q; Li S; Xie J; Teng L
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27763492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-lipid hybrid systems used as carriers for insulin delivery.
    Grigoras AG
    Nanomedicine; 2017 Nov; 13(8):2425-2437. PubMed ID: 28821465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lateral surface engineering of hybrid lipid-BCP vesicles and selective nanoparticle embedding.
    Schulz M; Olubummo A; Bacia K; Binder WH
    Soft Matter; 2014 Feb; 10(6):831-9. PubMed ID: 24837370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening strategies for surface modification of lipid-polymer hybrid nanoparticles.
    Rouco H; García-García P; Évora C; Díaz-Rodríguez P; Delgado A
    Int J Pharm; 2022 Aug; 624():121973. PubMed ID: 35811041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt, shake, fuse--giant hybrid polymer/lipid vesicles through mechanically activated fusion.
    Henderson IM; Paxton WF
    Angew Chem Int Ed Engl; 2014 Mar; 53(13):3372-6. PubMed ID: 24554375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN).
    Li Y; Taulier N; Rauth AM; Wu XY
    Pharm Res; 2006 Aug; 23(8):1877-87. PubMed ID: 16850265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.